Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kathleen E, Squires"'
Autor:
Kathleen E, Squires, Benjamin, Young, Edwin, DeJesus, Nicholaos, Bellos, Daniel, Murphy, Douglas, Ward, Henry H, Zhao, Lisa L, Ross, Mark S, Shaefer, B, Young
Publikováno v:
HIV Clinical Trials. 13:233-244
The open-label study ARIES (ClinicalTrials.gov NCT00440947) utilized a ritonavir (/r)-boosted protease inhibitor treatment simplification strategy. Antiretroviral-naïve subjects received abacavir/lamivudine (ABC/3TC) + atazanavir/ ritonavir (ATV/r)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13cba22eb024cbc7cd4132281202a4fb
https://doi.org/10.1310/hct1305-233
https://doi.org/10.1310/hct1305-233
Autor:
Kathleen E, Squires, Benjamin, Young, Edwin, Dejesus, Nicholaos, Bellos, Daniel, Murphy, Henry H, Zhao, Lisa G, Patel, Lisa L, Ross, Paul G, Wannamaker, Mark S, Shaefer, B, Young
Publikováno v:
AIDS. 24:2019-2027
Background Treatment simplification strategies involving induction with a ritonavir (RTV)-boosted (/r) protease inhibitor regimen followed by simplification (without RTV) are appealing because they may offer sustained virologic suppression while mini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8af5c8065e459f2d6c6832895c7674
https://doi.org/10.1097/qad.0b013e32833bee1b
https://doi.org/10.1097/qad.0b013e32833bee1b
Autor:
Raphael P. Viscidi, Linda Ahdieh‐Grant, Barbara Clayman, Kelly Fox, Leslie S. Massad, Susan Cu‐Uvin, Keerti V. Shah, Kathryn M. Anastos, Kathleen E. Squires, Ann Duerr, Denise J. Jamieson, Robert D. Burk, Robert S. Klein, Howard Minkoff, Joel Palefsky, Howard Strickler, Paula Schuman, Eva Piessens, Paolo Miotti
Publikováno v:
The Journal of Infectious Diseases. 187:194-205
Baseline serum samples from 2815 human immunodeficiency virus (HIV)-positive and 963 HIV-negative women enrolled in 2 cohort studies were tested for immunoglobulin G antibodies to human papillomavirus type 16 (HPV-16) capsids. HPV-16 seropositivity w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da8f1c73142916add484dcbed8c594e4
https://doi.org/10.1086/346052
https://doi.org/10.1086/346052
Autor:
Gail, Skowron, Daniel R, Kuritzkes, Melanie A, Thompson, Kathleen E, Squires, S Diane, Goodwin, Betsy A, Dusak, Jerry M, Tolson, Michael, Stevens, Geoffrey J, Yuen, James F, Rooney
Publikováno v:
The Journal of Infectious Diseases. 186:1028-1033
A 48-week open-label study of 11 antiretroviral-naive, human immunodeficiency virus type 1 (HIV-1)-infected adults evaluated once-daily treatment with adefovir dipivoxil, lamivudine, didanosine, and efavirenz. At baseline, the median plasma HIV-1 RNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d97d76242bbb4a4018bced2047afb7f
https://doi.org/10.1086/343740
https://doi.org/10.1086/343740
Autor:
Kathleen E, Squires, Linda-Gail, Bekker, Joseph J, Eron, Benjamin, Cheng, Juergen K, Rockstroh, Farid, Marquez, Princy, Kumar, Melanie, Thompson, Rafael E, Campo, Karam, Mounzer, Kim M, Strohmaier, Chengxing, Lu, Anthony, Rodgers, Beth E, Jackson, Larissa A, Wenning, Michael, Robertson, Bach-Yen T, Nguyen, Peter, Sklar, H, Albrecht
The racial diversity and gender distribution of HIV-infected patients make it essential to confirm the safety and efficacy of raltegravir in these populations. A multicenter, open-label, single-arm observational study was conducted in a diverse cohor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e02d054fa2d0b7091142579223f3458c
Autor:
Scott M, Hammer, Heather, Ribaudo, Roland, Bassett, John W, Mellors, Lisa M, Demeter, Robert W, Coombs, Judith, Currier, Gene D, Morse, John G, Gerber, Ana I, Martinez, William, Spreen, Margaret A, Fischl, Kathleen E, Squires, Neel, French
Publikováno v:
HIV clinical trials. 11(6)
Maximizing the durability of viral suppression is a key goal of antiretroviral therapy. The objective of AIDS Clinical Trials Group Study 372A was to determine whether the intensification strategy of adding abacavir to an effective indinavir-dual nuc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a7d1d32319da6140307bbd14c8e021c0
https://pubmed.ncbi.nlm.nih.gov/21239359
https://pubmed.ncbi.nlm.nih.gov/21239359
Autor:
Emily Abramson-Chen, Jennifer E. Agrusa, Jennifer L. Aldrich, Asma Ali, Kelly C. Allison, Lucinda S. Antosh, Janine M. Barsoum, Maureen E. Basha, Renee M. Bassaly, Katherine A. Belden, Michael Belden, Dale Berg, Katherine Berg, Jessica L. Bienstock, Gary D. Blake, Matthew P. Boente, Stephanie B. Boswell, Linda Bradley, Norman A. Brest, Ari D. Brooks, James F. Burke, Patricia I. Carney, Dmitri Chamchad, Robin M. Ciocca, Jonathan C. Cook, Michael F. Crutchlow, Diana Curran, Deborah M. Davenport, Ronit K. Devon, Philip J. DiGiacomo III, Alan E. Donnenfeld, Mitchell I. Edelson, Chad O. Edwards, Michelle M. Edwards, Ernest M. Enzien, Michael S. Ferrell, Joseph S. Ferroni, Sandra Fine, Mark O. Finnegan, Benjamin Fogel, Donald G. Gallup, Andrew Gerson, Brett C. Gilbert, Stephen E. Gordon, Linnea S. Hauge, Randolph P. Heinzel, David Holtz, Mark J. Ingerman, Keith Isaacson, Gerald A. Isenberg, Kirsten Jacobson, Daron A. Kahn, Joanne Kakaty-Monzo, Richard D. Kaplan, Joan A. Keegan, Carey L. Keiter, Stephen P. Krell, Leah Lande, Kimberly M. Lenhardt, Lawrence L. Livornese, Barry D. Mann, Sara N. Mann, Gregory Margolin, Pinckney J. Maxwell, Kristen M. McCullen, Garo Megerian, Shahab S. Minassian, Gennady G. Miroshnichenko, Benjamin E. Montgomery, Jessica M. Mory, Dionissios Neofytos, Debra Nestel, Suzanne S. Nogami, John J. Orris, Mehdi Parva, Gerald W. Peden, Christian M. Perez, William H. Pfeffer, Joel Port, Paul S. Robbins, Nancy S. Roberts, Norman G. Rosenblum, Camilo A. Ruiz, Sutthichai Sae-Tia, Cynthia Carrole Sagullo, Khaled H. Sakhel, Peter A. Schwartz, Anthony C. Sciscione, David E. Seubert, William R. Short, Randi Silibovsky, Arlene Smalls, Cynthia D. Smith, Kaighn Smith, Kathleen E. Squires, Caren M. Stalburg, Hindi E. Stohl, Vonetta T. Sylvestre, Linda M. Szymanski, Paula M. Termuhlen, Marc R. Toglia, Sue-Anne Toh, Allan R. Tunkel, Beverly M. Vaughn, Michelle Vichnin, Thomas A. Wadden, Neelesh Welling, Mary Grady Walsh, Frank J. White, Mark B. Woodland, Anthony Lee Yu, Harry G. Zegel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8224007a0323f34a255c2e2ed68b4d5
https://doi.org/10.1016/b978-1-4160-4896-1.00015-0
https://doi.org/10.1016/b978-1-4160-4896-1.00015-0
Autor:
Kathleen E, Squires
Publikováno v:
Research initiative, treatment action : RITA. 12(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fdc9a59aa926c3612bf7d1930c5401d7
https://pubmed.ncbi.nlm.nih.gov/17489118
https://pubmed.ncbi.nlm.nih.gov/17489118
Autor:
Roy M, Gulick, Heather J, Ribaudo, Cecilia M, Shikuma, Christina, Lalama, Bruce R, Schackman, William A, Meyer, Edward P, Acosta, Jeffrey, Schouten, Kathleen E, Squires, Christopher D, Pilcher, Robert L, Murphy, Susan L, Koletar, Margrit, Carlson, Richard C, Reichman, Barbara, Bastow, Karin L, Klingman, Daniel R, Kuritzkes
Publikováno v:
JAMA. 296(7)
Three-drug antiretroviral regimens are standard of care for initial treatment of human immunodeficiency virus 1 (HIV-1) infection, but a 4-drug regimen could improve antiretroviral activity and be more effective than a 3-drug regimen.To compare the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::af6c3131ece54b10c69e64bb585b6485
https://pubmed.ncbi.nlm.nih.gov/16905783
https://pubmed.ncbi.nlm.nih.gov/16905783